ABAXIS Inc. (ABAX) - 5i Research

ABAXIS Inc. (ABAX $83.00)
- $83.00 Cap: $1.89B
- View ABAX Profile
- View Questions on ABAX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Exact Sciences Corporation (EXAS $52.99)
- $52.99 Cap: $9.99B
- View EXAS Profile
- View Questions on EXAS
ABAXIS Inc. (ABAX $83.00)
- $83.00 Cap: $1.89B
- View ABAX Profile
- View Questions on ABAX

Q: Hi 5i,
Looking to increase US exposure to healthcare stocks and narrowed down to EXAS, , NVRO, NUVA and ABAX. In your opinion which companies offer healthy growth in short to long term and given a choice which 2 companies would you pick based on forward P/E, PEG and price momentum? Thanks so much.

Read Answer Asked by Sean on January 15, 2018